Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;28:1123-1125

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caulfield, M.
Right arrow Articles by Clark, A. J.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caulfield, M.
Right arrow Articles by Clark, A. J.L.

(Hypertension. 1996;28:1123-1125.)
© 1996 American Heart Association, Inc.


Articles

Angiotensinogen in Human Essential Hypertension

Mark Caulfield; Paul Lavender; John Newell-Price; Sejal Kamdar; Martin Farrall; Adrian J.L. Clark

the Departments of Clinical Pharmacology (M.C., S.K.) and Molecular Endocrinology/Endocrinology (J.N.-P., P.L., A.J.L.C.), St Bartholomew's Hospital, London, and The Wellcome Trust Centre for Human Genetics, Windmill Road, Oxford (M.F.), UK.

The candidacy of angiotensinogen for a role in the genetic basis of hypertension is supported by the observation that plasma angiotensinogen levels track with raised blood pressure through families. In addition, transgenic mice with overexpression of a rat angiotensinogen gene develop hypertension, and knockout mice with a disrupted gene and absent angiotensinogen production develop low blood pressure. There are now two studies in populations of white European origin and one in African Caribbeans providing support for a role of the angiotensinogen gene locus in human essential hypertension.


Key Words: angiotensinogen • genetics • hypertension, essential




This article has been cited by other articles:


Home page
Diabetes and Vascular Disease ResearchHome page
L. K. Summers
Adipose tissue metabolism, diabetes and vascular disease -- lessons from in vivo studies
Diabetes and Vascular Disease Research, May 1, 2006; 3(1): 12 - 21.
[Abstract] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. Serazin, M.-N. Dieudonne, M. Morot, P. de Mazancourt, and Y. Giudicelli
cAMP-positive regulation of angiotensinogen gene expression and protein secretion in rat adipose tissue
Am J Physiol Endocrinol Metab, March 1, 2004; 286(3): E434 - E438.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. C. Pereira, G. F.A. Mota, R. S. Cunha, F. L. Herbenhoff, J. G. Mill, and J. E. Krieger
Angiotensinogen 235T Allele "Dosage" Is Associated With Blood Pressure Phenotypes
Hypertension, January 1, 2003; 41(1): 25 - 30.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. D. McCole, M. D. Brown, G. E. Moore, R. E. Ferrell, K. R. Wilund, A. Huberty, L. W. Douglass, and J. M. Hagberg
Angiotensinogen M235T polymorphism associates with exercise hemodynamics in postmenopausal women
Physiol Genomics, August 14, 2002; 10(2): 63 - 69.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
F. C. Luft
Molecular Genetics of Salt-Sensitivity and Hypertension
Drug Metab. Dispos., April 1, 2001; 29(4): 500 - 504.
[Abstract] [Full Text]


Home page
J. Am. Soc. Nephrol.Home page
J.-M. LALOUEL, A. ROHRWASSER, D. TERREROS, T. MORGAN, and K. WARD
Angiotensinogen in Essential Hypertension: From Genetics to Nephrology
J. Am. Soc. Nephrol., March 1, 2001; 12(3): 606 - 615.
[Abstract] [Full Text]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
Jianhua Zhu and Danchen Gao
Losartan reduces collagen content and intimal thickening of iliac arteries after balloon injury in rabbits
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2000; 1(3): 278 - 282.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Rankinen, J. Gagnon, L. Perusse, Y. C. Chagnon, T. Rice, A. S. Leon, J. S. Skinner, J. H. Wilmore, D. C. Rao, and C. Bouchard
AGT M235T and ACE ID polymorphisms and exercise blood pressure in the HERITAGE Family Study
Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H368 - H374.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Engeli, R. Negrel, and A. M. Sharma
Physiology and Pathophysiology of the Adipose Tissue Renin-Angiotensin System
Hypertension, June 1, 2000; 35(6): 1270 - 1277.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. A. Wright, D. T. O'Connor, E. Roberts, G. Kutey, C. C. Berry, L. U. Yoneda, D. Timberlake, and G. Schlager
Genome Scan for Blood Pressure Loci in Mice
Hypertension, October 1, 1999; 34(4): 625 - 630.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. Kato, T. Sugiyama, H. Morita, T. Nabika, H. Kurihara, Y. Yamori, and Y. Yazaki
Lack of Evidence for Association Between the Endothelial Nitric Oxide Synthase Gene and Hypertension
Hypertension, April 1, 1999; 33(4): 933 - 936.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. St. Lezin, L. Zhang, Y. Yang, J.-M. Wang, N. Wang, N. Qi, J. S. Steadman, W. Liu, V. Kren, V. Zidek, et al.
Effect of Chromosome 19 Transfer on Blood Pressure in the Spontaneously Hypertensive Rat
Hypertension, January 1, 1999; 33(1): 256 - 260.
[Abstract] [Full Text] [PDF]